Sena ES, Briscoe CL, Howells DW, Donnan GA, Sandercock PA, Macleod MR (2010) Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis
As soon as they develop PDR, they should be referred to an ophthalmologist for management with either anti-VEGF injections or panretinal photocoagulation to prevent vision loss
Notes : Important considerations, such as administration route (SubQ, IM, Nasal), stacking advice, or unique side effects
Insulin was analyzed using an ELISA from Mercodia (Uppsala, Sweden), and glucose was analyzed using a commercially available kit (Infinity Glucose Oxidase) from Thermo Fisher Scientific (Lexington, MA, USA)